Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Acme Elixirs is a California-based healthcare and wellness company specializing in the development of high-purity cannabis concentrates and infused products. The company utilizes advanced CO2 extraction and distillation technologies to produce a range of 'elixirs' and vape cartridges characterized by their precise cannabinoid profiles. Their product portfolio is primarily divided into THC-dominant and CBD-dominant formulations, targeting therapeutic areas such as chronic pain management, anxiety, and sleep disorders. Acme Elixirs emphasizes laboratory testing and quality control to ensure safety and consistency in the rapidly evolving legal cannabis market. As a commercial-stage entity, the company focuses on the retail distribution of its proprietary formulations through licensed dispensaries.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Acme Elixirs.